Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction.

In a real-world national cohort of patients with HFpEF, spironolactone use reduced all-cause death and demonstrated a favorable trend in reducing the burden of hospitalizations.